Learning objective
By the end of this lesson, you can identify what is genuinely new in a growth option and design a proportionate evidence test.
Why it matters
The same label can hide different exposure. Selling an “existing” product in a new market may require new compliance, channel and workflow capabilities. The matrix is useful when it reveals novelty rather than understates it.
Core concept: classify novelty, then test it
For each option, ask what is new in:
- customer need;
- buyer and channel;
- product capability;
- operating model;
- regulation;
- brand permission.
The quadrant is a summary. The novelty profile determines the test.
Visual explanation
Worked example
Option: sell Northstar’s salon scheduler to clinics.
Provisional classification: market development.
Novelty profile:
| Dimension | Existing or new? | Evidence need |
|---|---|---|
| Core calendar | Existing | Workflow fit |
| Consent and audit | New | Procurement requirement |
| Buyer | New | Buying process and willingness to pay |
| Sales channel | New | Acquisition cost |
| Support model | Partly new | Clinical escalation expectations |
The smallest credible test is not a national launch. It may be a paid, fixed-scope pilot with two clinics and a manual audit export.
Common mistake
Mistake: assuming diversification is always the riskiest quadrant.
A closely related new service for a known adjacent market may be less risky than “market penetration” that depends on expensive price competition. Risk comes from assumptions and exposure, not only location in the matrix.
Quick check
An existing product is sold through a new partner to the same customer segment. Which answer is best?
A. It must be market penetration.
B. It must be market development.
C. The market may be existing, but the new channel creates execution novelty that the quadrant alone does not show.
D. It is diversification.
Answer: C.
Practical prompt
Take one proposed growth option. Classify its quadrant, then list the two most consequential forms of novelty. Design one test that could disconfirm each.
Summary
- The matrix makes product and market novelty explicit.
- Quadrants do not determine risk automatically.
- Tests should target the most consequential novelty.
Next lesson
Continue to BCG Matrix to examine how growth bets compete with existing portfolio units for capital and attention.